ES376981A1 - Sydnonimine derivatives - Google Patents
Sydnonimine derivativesInfo
- Publication number
- ES376981A1 ES376981A1 ES376981A ES376981A ES376981A1 ES 376981 A1 ES376981 A1 ES 376981A1 ES 376981 A ES376981 A ES 376981A ES 376981 A ES376981 A ES 376981A ES 376981 A1 ES376981 A1 ES 376981A1
- Authority
- ES
- Spain
- Prior art keywords
- heterocyclic ring
- substituted
- cycloalkyl
- halogen
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/04—1,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Compounds of the general formula (R 1 , 2 = alkyl, cycloalkyl, aralkyl optionally substituted by CH 3 or halogen, heterocyclic ring linked via alkylene chain to N, or -NR 1 R 2 = heterocyclic ring optionally containing more than one heteroatom and/or being substituted by CH 3 R 3 = H, -COR 4 (R4 = alkyl, cycloalkyl, Ph, halophenyl, alkoxy, unsubstituted or substituted nitrogen-containing heterocyclic ring) Hal = halogen) and their acid addition salts are prepared by halogenating a compound of the formula or an acid addition salt thereof, optionally followed by deacylation and/or salt formation. The preparation of the starting materials by standard methods is described. The above compounds are hypotensive agents, and the salts may be administered in the form of pharmaceutical preparations containing them in association with a carrier.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19681770061 DE1770061A1 (en) | 1968-03-26 | 1968-03-26 | New substituted 3-amino-4-bromosydnomimines |
Publications (1)
Publication Number | Publication Date |
---|---|
ES376981A1 true ES376981A1 (en) | 1972-05-01 |
Family
ID=5700383
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES364979A Expired ES364979A1 (en) | 1968-03-26 | 1969-03-20 | Sydnonimine derivatives |
ES376981A Expired ES376981A1 (en) | 1968-03-26 | 1970-02-27 | Sydnonimine derivatives |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES364979A Expired ES364979A1 (en) | 1968-03-26 | 1969-03-20 | Sydnonimine derivatives |
Country Status (18)
Country | Link |
---|---|
AT (1) | AT285619B (en) |
BE (1) | BE730510A (en) |
BG (1) | BG15220A3 (en) |
BR (1) | BR6907417D0 (en) |
CA (1) | CA945990A (en) |
CH (1) | CH519511A (en) |
DE (1) | DE1770061A1 (en) |
DK (1) | DK130296B (en) |
ES (2) | ES364979A1 (en) |
FI (1) | FI54480C (en) |
FR (1) | FR2004770A1 (en) |
GB (1) | GB1219254A (en) |
HU (1) | HU162735B (en) |
IE (1) | IE32708B1 (en) |
IL (1) | IL31909A (en) |
NL (1) | NL6904632A (en) |
SE (1) | SE374746B (en) |
YU (1) | YU69369A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2930736A1 (en) | 1979-07-28 | 1981-02-12 | Cassella Ag | PHARMACOLOGICALLY ACTIVE, SUBSTITUTED 3-AMINO-SYDNONIMINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE |
-
1968
- 1968-03-26 DE DE19681770061 patent/DE1770061A1/en active Pending
-
1969
- 1969-03-04 FI FI644/69A patent/FI54480C/en active
- 1969-03-18 CH CH409069A patent/CH519511A/en not_active IP Right Cessation
- 1969-03-20 ES ES364979A patent/ES364979A1/en not_active Expired
- 1969-03-21 BR BR207417/69A patent/BR6907417D0/en unknown
- 1969-03-21 YU YU00693/69A patent/YU69369A/en unknown
- 1969-03-25 IE IE400/69A patent/IE32708B1/en unknown
- 1969-03-25 BG BG011905A patent/BG15220A3/en unknown
- 1969-03-25 AT AT293569A patent/AT285619B/en not_active IP Right Cessation
- 1969-03-25 SE SE6904193A patent/SE374746B/xx unknown
- 1969-03-25 DK DK165269AA patent/DK130296B/en unknown
- 1969-03-25 HU HUBO1177A patent/HU162735B/hu unknown
- 1969-03-26 GB GB05910/69A patent/GB1219254A/en not_active Expired
- 1969-03-26 FR FR6908875A patent/FR2004770A1/fr active Pending
- 1969-03-26 CA CA046,827A patent/CA945990A/en not_active Expired
- 1969-03-26 BE BE730510D patent/BE730510A/xx unknown
- 1969-03-26 NL NL6904632A patent/NL6904632A/xx not_active Application Discontinuation
- 1969-03-26 IL IL31909A patent/IL31909A/en unknown
-
1970
- 1970-02-27 ES ES376981A patent/ES376981A1/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
CA945990A (en) | 1974-04-23 |
YU69369A (en) | 1978-09-18 |
DE1770061A1 (en) | 1971-09-16 |
ES364979A1 (en) | 1971-02-16 |
BR6907417D0 (en) | 1973-04-12 |
GB1219254A (en) | 1971-01-13 |
IL31909A0 (en) | 1969-05-28 |
DK130296B (en) | 1975-02-03 |
FI54480B (en) | 1978-08-31 |
DK130296C (en) | 1975-06-30 |
CH519511A (en) | 1972-02-29 |
IL31909A (en) | 1973-01-30 |
HU162735B (en) | 1973-04-28 |
IE32708B1 (en) | 1973-10-31 |
BE730510A (en) | 1969-09-26 |
FR2004770A1 (en) | 1969-11-28 |
BG15220A3 (en) | 1975-11-21 |
IE32708L (en) | 1969-09-26 |
AT285619B (en) | 1970-11-10 |
NL6904632A (en) | 1969-09-30 |
SE374746B (en) | 1975-03-17 |
FI54480C (en) | 1978-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1409693A (en) | Triazolobenzodiazepines | |
GB1418822A (en) | Imidazo-and pyrimido-2,1-b-quinazolin-2-ones and a process for the preparation thereof | |
ES368973A1 (en) | Derivatives of (benzimidazolyl-2-methyl) piperazine and their process of preparation | |
GB1456627A (en) | Pyridobenzodiazepinones | |
GB1297386A (en) | ||
GB1367785A (en) | 2-substituted adenosine derivatives and the production thereof | |
GB1323659A (en) | Piperazine derivatives methods for their production and pharmaceuticl compositions containing them | |
GB1394568A (en) | Diazepine derivatives and process for the production thereof | |
GB1434805A (en) | 5-phenoxy-4-amino pyrimidines | |
GB1443692A (en) | 1,2-diphenylethanolamine derivatives and their salts and the preparation thereof | |
ES364979A1 (en) | Sydnonimine derivatives | |
GB1346710A (en) | Antibacterial compositions | |
GB1206088A (en) | New pyrazolodiazepinone compounds and methods for their production | |
GB1168108A (en) | Amide Derivatives of 1-Piperazine Acetic Acid and Process for their Preparation | |
GB1449078A (en) | Phenoxyethylamine derivatives | |
GB1465783A (en) | Pyrrolyl compounds and processes for their manufacture | |
GB1345214A (en) | Isoxazoles | |
GB1449426A (en) | Phenoxyalkylamine derivatives and preparation therof | |
GB1433103A (en) | Pharmacologically active pyrrolodiazepines | |
GB1160064A (en) | Indole Derivatives | |
GB1307256A (en) | Piperazine derivatives and a process for their preparation | |
GB1412932A (en) | Pharmaceutically active leurosine derivatives and preparation thereof | |
GB1369580A (en) | Tricyclic diphenylamine derivatives | |
GB1338459A (en) | Flavanone derivatives and process for inhibiting growth of microorganisms using such compounds | |
GB1222947A (en) | Thiophene derivatives |